Vietnam Artemisinic Acid Market to Grow with a CAGR of 4.23% through 2030
Cost-effectiveness of Artemisinic
acid production and advances in biotechnology is expected to drive the Vietnam Artemisinic
Acid Market growth in the forecast period, 2026-2030.
According to TechSci Research report, “Vietnam Artemisinic
Acid Market - By Region, Competition, Forecast and Opportunities, 2030F”,
the Vietnam Artemisinic Acid Market stood at USD 2.01 Million in 2024 and is expected
to reach USD 2.58 Million by 2030 with a CAGR of 4.23% during the forecast
period.
The Vietnam
Artemisinic Acid Market has experienced considerable growth and transformation
in recent years, driven by both domestic and global factors. As Vietnam
continues to battle malaria, the demand for artemisinin-based therapies (ACTs)
has escalated, leading to a growing need for artemisinic acid, a key
intermediate in the production of artemisinin. The country’s strong focus on improving
public health outcomes, particularly in regions with high malaria incidence,
and the Vietnamese government’s commitment to self-sufficiency in
pharmaceutical production are major drivers of the market’s expansion.
Artemisinic acid
is a naturally occurring compound derived from the Artemisia annua plant, and
it serves as the precursor to artemisinin, the active ingredient in ACTs, which
are widely used to treat malaria. While the plant remains a significant source of
artemisinic acid, biotechnological methods, such as microbial fermentation,
have emerged as an alternative, enabling the large-scale, cost-effective
production of artemisinic acid. Vietnam’s emphasis on adopting these innovative
methods, alongside the growing interest in biotechnological advancements, has
contributed to the increased local production of artemisinic acid, reducing
reliance on imports and bolstering the local pharmaceutical industry.
Southern Vietnam
has emerged as the dominant region in the artemisinic acid market, largely due
to its economic infrastructure and the concentration of pharmaceutical
manufacturing facilities in cities like Ho Chi Minh City. This region benefits
from a highly developed industrial base, including well-established supply
chains, access to skilled labor, and proximity to ports for international
trade. These factors have allowed Southern Vietnam to scale up the production
of artemisinic acid efficiently. Southern Vietnam plays a central role in
global pharmaceutical exports, and as the demand for artemisinin-based
therapies continues to grow worldwide, local manufacturers are well-positioned
to meet both domestic and international needs.
Government
policies have been pivotal in supporting the growth of the artemisinic acid
market. The Vietnamese government has implemented public health initiatives
aimed at reducing the burden of malaria, including national malaria elimination
programs that focus on improving access to affordable antimalarial drugs. This
aligns with the broader objective of reducing the country’s dependence on
imported medicines and increasing the domestic production of essential drugs
like artemisinic acid. By fostering a domestic supply chain, the government is
not only addressing public health concerns but also ensuring that Vietnamese
manufacturers can meet the growing demand for artemisinin-based therapies and
artemisinic acid.
Vietnam's
commitment to sustainability and self-sufficiency has further bolstered the
market. There is a clear effort to reduce reliance on foreign imports of active
pharmaceutical ingredients (APIs), and as a result, local production of
artemisinic acid is gaining traction. With the government supporting local
R&D and biotechnological innovations, the Vietnamese pharmaceutical
industry is working to enhance production capabilities while ensuring the
sustainability of malaria treatments. As more companies invest in biotech-based
methods like microbial fermentation, the market is expected to witness further
growth, leading to improved production scalability and a stable supply of
artemisinic acid.
While Southern
Vietnam leads the market, other regions such as Central Vietnam and Northern
Vietnam are also contributing to the overall development of the artemisinic
acid market. Northern Vietnam has made strides in pharmaceutical manufacturing,
particularly in cities like Hanoi, and has seen some involvement in artemisinic
acid production. However, the region’s pharmaceutical industry is still
catching up in terms of infrastructure and technological adoption compared to
the south. Central Vietnam, which includes cities like Da Nang, is similarly
not as heavily involved in the production of artemisinic acid, resulting in a
more modest contribution to the market. However, these regions continue to play
important roles in the overall distribution of artemisinin-based treatments, as
well as in expanding healthcare access to underserved populations.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "Vietnam Artemisinic Acid Market”
The Vietnam Artemisinic Acid Market is segmented into type,
regional distribution, and company.
Based on type, Antimalarial injections are the second
dominant segment in the Vietnam Artemisinic Acid Market, although they do not
command the same market share as antimalarial tablets. Their relatively smaller
share can be attributed to their specific use cases and more complex
requirements compared to oral formulations. Despite this, antimalarial
injections remain a critical part of malaria treatment in Vietnam, especially
for severe cases of malaria, and thus contribute significantly to the demand
for artemisinic acid.
One of the primary reasons antimalarial injections are
still an essential part of the artemisinic acid market in Vietnam is due to the
effectiveness of these injections in treating severe malaria, which can be
life-threatening if not treated promptly. In cases of severe falciparum
malaria, where the malaria parasite infects the bloodstream and causes symptoms
like cerebral malaria, kidney failure, or severe anemia, injectable artemisinin
derivatives such as artemether or arteether are used as the treatment of
choice. These injectable forms are administered in hospital settings, where
rapid absorption and onset of action are crucial. This makes them indispensable
for patients in critical conditions, where oral medications may not be
effective or quickly absorbed.
Based on region, Northern Vietnam is the dominant
region in the Vietnam Artemisinic Acid Market, though it is essential to note
that the region’s contribution to the market is driven by specific factors such
as the location of pharmaceutical manufacturing facilities, strategic public
health initiatives, and a focus on malaria control efforts. While Southern
Vietnam plays a significant role due to its advanced industrial base and high
concentration of pharmaceutical companies, Northern Vietnam holds a unique
position in the artemisinic acid market due to its emphasis on healthcare
infrastructure, government support, and supply chain connectivity for
antimalarial treatments. Hanoi, the capital of Vietnam, is located in Northern
Vietnam, and it is the hub for governmental activities related to public health
and pharmaceutical regulation. As the government’s policymaking center,
Northern Vietnam plays a significant role in the development and implementation
of malaria control programs. This includes large-scale public health
initiatives to combat malaria, which involve both prevention and treatment
strategies. The region benefits from a strong focus on access to medicines,
including artemisinic acid and artemisinin-based therapies (ACTs), which are
pivotal in the treatment of malaria. The government’s investment in public
health and efforts to make antimalarial drugs more accessible are key drivers
of the artemisinic acid market in Northern Vietnam.
Northern Vietnam also sees a significant number of
malaria cases, particularly in mountainous and rural areas where access to
healthcare may be limited. The country’s northern provinces are closer to China
and Laos, where malaria transmission rates have been historically higher,
making Northern Vietnam an area of particular focus for malaria elimination
efforts. The demand for artemisinin-based therapies and, consequently, for
artemisinic acid, is substantial in these regions to support local treatment programs
and ensure that malaria cases are effectively managed.
Major companies
operating in the Vietnam Artemisinic Acid Market are:
- Bayer Vietnam Ltd.
- DHG Pharmaceutical Joint Stock Company
- Cipla Limited
- Novartis Vietnam Company Limited
- Domesco Medical Import Export Joint Stock Corporation
(DOMESCO)
- OPC Pharmaceutical Joint Stock Company
- Sanofi-Aventis Vietnam
- Mekophar Chemical and Pharmaceutical JSC
- Imexpharm Pharmaceutical Joint Stock Company
- Pymepharco Joint Stock Company
Download Free Sample Report
Customers can
also request 10% free customization on this report
“The future of
the Vietnam Artemisinic Acid Market looks promising, driven by the growing
demand for effective malaria treatments and the country’s commitment to
self-sufficiency in pharmaceutical production. As the Vietnamese government
continues to invest in healthcare infrastructure and malaria control programs,
there will be an increasing focus on domestic production of artemisinic acid to
meet local and regional needs. Advancements in biotechnology, such as microbial
fermentation, will drive the cost-effective and sustainable production of
artemisinic acid, reducing dependency on imports. The market will also benefit
from the rising demand for affordable antimalarial therapies and the shift
toward oral and injectable treatments. With ongoing efforts to enhance public
health accessibility and regional supply chains, the artemisinic acid market is
poised for robust growth in the coming years.,” said Mr. Karan Chechi, Research
Director of TechSci Research, a research-based management consulting firm.
“Vietnam
Artemisinic Acid Market By Type (Antimalarial Injections and Antimalarial
Tablets), By
Region, Competition, Forecast and
Opportunities, 2020-2030F”, has evaluated
the future growth potential of Vietnam Artemisinic Acid Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision-makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Vietnam Artemisinic Acid Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com